24U-37277-27136
4 vaccinations
7 coded responses
39 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 350 / AL
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 1 — Pfizer-BioNTech
-
2021-02-10
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-24
-
2021-03-03
Dose 2 — Pfizer-BioNTech
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Diarrhea · Be unable to workAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-10
-
2021-03-17
Survey response — day 14, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodes under left armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
-
2021-06-02
Survey response — 3 months, dose 2MedDRA: Dyspnoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-02
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
- 2021-09-01
-
2021-10-10
Dose 3 — Pfizer-BioNTech
-
2022-03-03
Survey response — 12 months, dose 2MedDRA: Deafness unilateral, Meniere's disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Lost hearing in left ear; diagnosed with Meniere's; no previous ear/hearing issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-04
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-10
-
2022-10-10
Survey response — 12 months, dose 3MedDRA: Diabetes mellitus — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: New onset diabetesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-11
-
2022-12-11
Dose 4 — Pfizer-BioNTech
- 2022-12-11
-
2022-12-12
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2022-12-13
-
2022-12-14
Survey response — days 1–6 daily, dose 4MedDRA: Blood glucose increased — Feeling: Poor · Muscle or body aches, Fatigue or tirednessFree text: High blood glucoseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-15
Survey response — days 1–6 daily, dose 4MedDRA: Blood glucose increased — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: High blood glucose levelsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Survey response — days 1–6 daily, dose 4MedDRA: Blood glucose increased — Feeling: Poor · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: High blood glucoseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-18
-
2022-12-25
Health check-in — day 14, dose 4Feeling: Poor · Be unable to do your normal daily activitiesFree text: Urinary urgencyAdult check-in · check-in free text available
- 2023-01-01
- 2023-01-08
- 2023-01-22
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
| 4 | 2022-12-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-02 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-03-03 | Successful 2022-03-04 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-10-10 | Unsuccessful |
Free text
Release 5 — day 14, dose 2
Symptoms: Swollen lymph nodes under left arm
Release 8 — 3 months, dose 2
Symptoms: Shortness of breath
Release 11 — 12 months, dose 2
Symptoms: Lost hearing in left ear; diagnosed with Meniere's; no previous ear/hearing issues
Release 12 — 12 months, dose 3
Symptoms: New onset diabetes
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): High blood glucose
Systemic reaction (other): High blood glucose levels
Systemic reaction (other): High blood glucose
Release 12 — day 14, dose 4
Symptoms: Urinary urgency
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Deafness unilateral | · | · | ✓ |
| SD | Diabetes mellitus | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Meniere's disease | · | · | ✓ |
| SRO | Blood glucose increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release